PhillyPharma Archive: November, 2012

Teva doesn't specify cuts of $1.5 billion to $2 billion

Comment icon 0 Comments
Leaders of Teva Pharmaceutical Industries announced financial projections for 2013 and said the company would cut costs by $1.5 billion to... Read more

Will Teva cut jobs but boost spending on R&D?

Comment icon 0 Comments
Leaders of Teva Pharmaceutical Industries will discuss their plans for 2013 Friday morning, according to a company news release that was distributed... Read more

Drug industry clinical trials and the resulting reports criticized

Comment icon 0 Comments
A Washington Post story the other day explained the conflict that some might think is inherent in pharmaceutical companies testing their own... Read more

Ranbaxy halts production of its generic Lipitor after another recall

Comment icon 0 Comments
Ranbaxy Pharmaceuticals has halted productions of its generic version of the cholesterol drug Lipitor after recalling a second batch of tablets... Read more

FTC supports generic Mylan in Philly suit against branded Warner Chilcott

Comment icon 0 Comments
Normal 0 false false false EN-US X-NONE X-NONE Read more

Glaxo investing more in India and Nigeria units

Comment icon 0 Comments
Drugmaker GlaxoSmith Kline said it will raise its stake in its consumer healthcare subsidiaries in India and Nigeria at a cost of more than... Read more

Ranbaxy recalls some of its generic Lipitor in the U.S.

Comment icon 0 Comments
Ranbaxy Pharmaceuticals Inc., the U.S. subsidiary of the Indian drugmaker, said Friday it is recalling some bottles of its generic version... Read more

Federal agency suggests HIV testing for everybody 15 to 65 years old

Comment icon 0 Comments
The U.S. Preventive Services Task Force suggested Monday that all people age 15 to 65 should be tested to see if they have HIV (human immunodeficiency... Read more